Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Zinc finger protein 124 (ZNF124) is a human protein encoded by the ZNF124 gene, characterized by an amino-terminal KRAB-A box and multiple C2H2-type Kruppel-like zinc finger motifs at its carboxy terminus. ZNF124 functions as a transcription factor, generally involved in nucleic acid binding and the regulation of gene expression. It is implicated in promoting cell survival by inhibiting apoptosis, as observed in response to VEGF in leukemia cell lines as well as in the aggressive growth and maintenance of group 3 medulloblastoma cells, where its elevated levels are linked to poor prognosis and increased tumor cell proliferation. Alternative splicing results in multiple ZNF124 isoforms. There are no well-established interacting drugs or safety concerns reported for this protein to date.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Zinc finger protein 124 (ZNF124).